Buttar, Rabinder (ClinTec 1997– CEO + Founder) |
Chief Executive Officer (CEO) |
ClinTec (Group) |
United Kingdom (GB) |
Butté, Alessandro (DataHow 202406 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
DataHow AG |
Switzerland |
Butterfield, Stewart (Slack Technologies 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Salesforce (Group) |
United States (USA) |
Buyse, Chris (Fund+ 201610 Managing Partner before ThromboGenics 201203 CFO) |
Managing Partner |
Fund+ N.V. |
Belgium |
Büchele, Wolfgang (Exyte 202207 CEO formerly Linde 201405 designated CEO + Board Chairman of Merck KGaA) |
Chief Executive Officer (CEO) |
Stumpf (Group) |
Germany |
Büchler, Andrea (Lunaphore 201808 Finance + Business Development) |
Business Development Manager / Strategy Manager |
Bio-Techne (Group) |
Switzerland |
Byczynski, Michael (Eppendorf 200803) |
n. a. |
Eppendorf (Group) |
Germany |
Bügling, Dieter (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
Bühler, Markus (Technologiepark Heidelberg 201504 Startup Support Manager) |
n. a. |
Heidelberg (govt city) |
Germany |
Bühler, Peter (Valneva 202107– CFO ANNOUNCED before Quotient + Zaluvida + Stallergenes Greer + Lilly + Merck Serono) |
Chief Financial Officer (CFO) |
Valneva (Group) |
France |
Bülow, Holger (Miltenyi 201901 Press Contact) |
Public Relations Manager / Investor Relations Manager |
Miltenyi Biotec (Group) |
Germany |
Bülow, Sven (Eppendorf 201104 EVP Corporate Developm before Director Eppendorf Biochip Systems) |
Business Development Manager / Strategy Manager |
Eppendorf (Group) |
Germany |
Büntemeyer, Heino (TeutoCell 201105 Executive Board Member) |
Board member, executive |
Xell AG |
Germany |
Bünter, Anna K. (Sallea 202311– CCO + Co-Founder) |
Chief Commercial Officer (CCO) |
Sallea AG |
Switzerland |
Bünz, Alexander (Knauer 2006–2014 Managing Director LEFT 2015) |
Managing Director |
Knauer (Group) |
Germany |
Bürger, Frank (Avida Group 200508 before WGZ-Bank) |
n. a. |
AVIDA Group (Dusseldorf) |
Germany |
Bürger, Mario (GeSiM 200604 Managing Director) |
Managing Director |
GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH |
Germany |
Bürgermeister, Torsten (Veraxa Biotech 202203– CFO before Molecular Health) |
Chief Financial Officer (CFO) |
Veraxa Biotech (Group) |
Germany |
Bürk, Jan-Hendrik (btov Partners 202010 Principal) |
Principal (venture capital) |
btov Partners (b-to-v Partners) (Group) |
Germany |
Bürk, Matthias (Merck (DE) 201409 Head of Human Resources Germany) |
Human Resources Manager |
Merck (DE) (Group) |
Germany |
Bürling, Philipp (Priavoid 202009– CEO formerly Numaferm GmbH 201702– Managing Director + Co-Founder) |
Chief Executive Officer (CEO) |
Priavoid GmbH |
Germany |
Bürmann, Martin (Rittershaus 200809 Mannheim) |
n. a. |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
Bürsgens, Federico (GNA Biosolutions 201908 Managing Director + Co-Founder) |
Managing Director |
GNA Biosolutions GmbH |
Germany |
Bütow, Sandra M. (Germany (govt) 201504 Senior Manager MedTech + Medical Biotech + Pharma at GTAI) |
n. a. |
Germany (govt) |
Germany |
Büttiker, Mathis (Endress+Hauser 201706– Supervisory Board Member main org Notenstein La Roche Privatbank AG) |
Supervisory Board Member |
Endress+Hauser (Group) |
Switzerland |
Bähr, Christa (CB Healthcare 201804) |
Analyst (Financial / Industry) |
CB Healthcare – Dr. Christa Bähr |
Germany |
Bähr, Cornelia (b.value 202104 Investment Manager) |
Investment Manager |
b.value (Group) |
Germany |
Bähr, Petra (Priaxon 200805 CEO) |
Chief Executive Officer (CEO) |
Priaxon AG |
Germany |
Bär, Lars (Celldeg GmbH 201609– Managing Director) |
Managing Director |
Celldeg GmbH |
Germany |
Bärsch, Niko (Particular GmbH 201105 Managing Director) |
Managing Director |
Particular GmbH |
Germany |
Bässmann, Carsten (Bruker 201306 Head of ESI Applications Development) |
Research & Development Manager |
Bruker (Group) |
United States (USA) |
Bäuerle, Patrick (MPM Capital 201710 Managing Director formerly Micromet) |
Managing Director |
MPM Capital (Group) |
United States (USA) |
Böge, Henning (Capical GmbH 201109 Managing Director + co-founder) |
Managing Director |
Capical GmbH |
Germany |
Böhm, Christian (NLC Venture 202210 Venture Partner) |
Venture Partner |
NLC Ventures (Group) |
Netherlands |
Böhm, Gerald (BIO-NET Leipzig 201210 Managing Director) |
Managing Director |
BIO-NET Leipzig Technologietransfergesellschaft mbH (Bio City Leipzig) |
Germany |
Böhme, Harry (c-LEcta GmbH 201509– CFO before CFO at Novaled AG) |
Chief Financial Officer (CFO) |
Kerry Group (Group) |
Germany |
Böhme, Marc (Amedo 201003– Managing Director responsible for Sales + Marketing) |
Managing Director |
Amedo Smart Tracking Solutions GmbH |
Germany |
Böhme, Silvana (Biostep 200512) |
n. a. |
Biostep GmbH |
Germany |
Bölke, Tim P. (BASF 201012 Managing Director of Metanomics Health GmbH) |
Managing Director |
Acousia Therapeutics GmbH |
Germany |
Bördgen, Anke (Knauer 201403 Head of Product Management) |
Product Manager (personnel) |
Knauer (Group) |
Germany |
Börner, Yannick L. (Carelane 202406 Managing Director + Co-Founder) |
Managing Director |
Carelane GmbH |
Germany |
Börnsen, Jens (Bremen (govt) 201308 Major) |
n. a. |
Bremen (govt region) |
Germany |
Bös, Michael (Acousia Therapeutics 201805 CSO before Affectis + Boehringer Ingelheim Canada) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Acousia Therapeutics GmbH |
Germany |
Bösche, Bernd (Schleswig-Holstein 201012 Managing Directort WTSH) |
Managing Director |
Schleswig-Holstein (govt region) |
Germany |
Bösenberg, Sabine (Aviso 200809) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
Bösl, Raphael (Isenbruck Bösl Hörschler 201511 Patent Attorney) |
Patent Attorney |
Isenbruck | Bösl | Hörschler LLP |
Germany |
Böttcher, Ute (GenExpress GmbH 201102 Managing Director) |
Managing Director |
GenExpress Gesellschaft für Proteindesign mbH |
Germany |
Böttcher-Lorenz, Juliane (MVZ für Mikrobiologie Dessau 200909 Managing Director) |
Managing Director |
MVZ für Mikrobiologie, Labordiagnostik und Hygiene Dessau GmbH |
Germany |
Cabirol, Fabien (L’Oréal 201501 Global Head of Biotechnologies Dept) |
President/Director/Head Business Group/Unit/Division |
L’Oréal (Group) |
France |
Cafazzo, Mark (Danaher 201601 Director Academic + Clinical Research Business at Sciex) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
Cafferkey, John (Novogene 202312 Marketing Director at Novogene Europe) |
Sales Manager / Marketing Manager |
Novogene (Group) |
United Kingdom (GB) |
Cagnoni, Pablo J. (Rubius Therapeutics 202207 CEO before MPM Capital + Tizona Tx + Blade Tx + OSI Pharma) |
Chief Executive Officer (CEO) |
MPM Capital (Group) |
United States (USA) |
Cai, Darren (Legend Capital 201706 Managing Director) |
Managing Director |
Legend Capital (CN) |
China |
Calais, Philippe (Antisense Pharma 201205– Managing Director CEO before Roche + ICI et al) |
Managing Director |
Isarna Therapeutics GmbH |
Germany |
Calaman, Greg (Definiens 200604– VP North America Operations) |
n. a. |
AstraZeneca (Group) |
Germany |
Calikowski, Tomasz (EU 201403 Scientific Officer of European Commission) |
Administrative Officer (personnel) |
|
|
Calleja, Montserrat (CSIC 201302 Dept Head at Bionanomechanics lab at IMM) |
Researcher (university / research institute) |
Spain (govt) |
Spain (España) |
Callori, Fred (Perceptive Advisors 202104 at Perceptive Xontogeny Venture Fund) |
Investment Manager |
Perceptive Advisors LLC |
United States (USA) |
Calzolari, Simone (ZeClinics 202102 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
ZeClinics (ES) |
Spain (España) |
Camardo, Joseph (Joe) (ADC Therapeutics 202206 CMO formerly Wyeth Pharma 200704 SVP of Global Medical Affairs) |
Chief Medical Officer (CMO) |
Pfizer (Group) |
United States (USA) |
Camblong, Jurgi (Sophia Genetics 201407 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Sophia Genetics (Group) |
Switzerland |
Cameron, Grant (Automation Partnership 201210 RAFT Development Director) |
Research & Development Manager |
Sartorius (Group) |
United Kingdom (GB) |
Caminelli, Silvano |
n. a. |
HBM (Group) |
Switzerland |
Campos, Renata (Takeda 201502 Managin Diretor Turkey) |
Managing Director |
Takeda (Group) |
Japan |
Canet, Emmanuel (Servier 200705 VP RnD) |
research & development (RnD, research and development) |
Servier (Group) |
France |
Cansier, Alexander (PANATecs 201003 Head Quality Assurance) |
n. a. |
Zukunftsfonds Heilbronn (Group) |
Germany |
Cantarell, Luis (Nestlé 201105 CEO of Nestlé Health Science SA) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
Switzerland |
Cantey, Danielle (UDG Healthcare 202108 at Canale Communciations before WPP 201909 Glover Park Group) |
Public Relations Manager / Investor Relations Manager |
Inizio (Group) |
United States (USA) |
Canton, Barry (Ginkgo Bioworks 202203 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Ginkgo Bioworks (Group) |
United States (USA) |
Capone, Mark C. (Myriad Genetics 201605 CEO) |
Chief Executive Officer (CEO) |
Myriad Genetics (Group) |
United States (USA) |
Cappia, Jean-Marc (201006 VP Marketing Fluid Management Technologies at Sartorius Stedim Biotech) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
France |
Cardella, Craig (Scienion 201112– Manager of Sciencion US Inc before Matrical Bioscience) |
General Manager (management) |
Bico (Group) |
United States (USA) |
Cardoen, Johan (VIB 201501 Managing Director) |
Managing Director |
VIB (Flanders Interuniversity Institute for Biotechnology / Vlaams Instituut voor Biotechnologie) |
Belgium |
Carell, Thomas (LMU 201410 Professor for Organic Chemistry + Founder of Baseclick GmbH) |
Professor |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
Cargill, Chris (Sosei 202307 CEO of Sosei Heptares) |
Chief Executive Officer (CEO) |
Nxera Pharma (Group) |
Japan |
Carius, Wolfram (Bayer 202012 Head of Cell + Gene Therapy Unit before Boehringer) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
Carl, Peter (SAFIA Technologies 202305 Managing Director + Co-Founder) |
Managing Director |
SAFIA Technologies GmbH |
Germany |
Carle, Vanessa (Forbion 202203– Associate before PharmaVentures + EPFL) |
venture capital |
Forbion (Group) |
Netherlands |
Carlisle, Ileana (Biotest 201605 CEO of Biotest Pharmaceuticals Corp) |
Chief Executive Officer (CEO) |
Grifols (Group) |
United States (USA) |
Carlson, Eric (Portein Metrics 201510 CBO) |
Chief Business Officer (CBO) |
Insightful Science (Group) |
United States (USA) |
Carlson, Margaret K. (Alira Health 202005 CFO) |
Chief Financial Officer (CFO) |
Alira Health (CMC Consulting Boston) (Group) |
United States (USA) |
Carmagnol, Caroline (Alize RP 201107 CEO + Founder) |
Chief Executive Officer (CEO) |
Alize RP (Public Relations) |
France |
Carman, Bill (Fast Track Diagnostics 201712 CEO) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Malta |
Carmona, Jose I. (Pepe) (ADC Therapeutics 202212– CFO before Rubius Therapeutics + Radius Health + Innocoll + Novartis) |
Chief Financial Officer (CFO) |
ADC Therapeutics (Group) |
Switzerland |
Carnot, Lionel (EarlyBird 202010 Partner + Bay City Capital 201608 Managing Director) |
Managing Director |
Bay City Capital LLC |
United States (USA) |
Caroff, Frederic (Hephaistos-Pharma 202401 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Hephaistos-Pharma (Group) |
France |
Caroli, Luis Eduardo (BioZeus 201409 CEO) |
Chief Executive Officer (CEO) |
BioZeus Desenvolvimento de Produtos Biofarmacêuticos S.A. |
Brazil |
Carouge, Dominique (Sanofi 201802– EVP Head of Business Transformation joined Sanofi 2009 before Ernst & Young) |
Business Development Manager / Strategy Manager |
Sanofi (Group) [since May 2011] |
France |
Carpenter, Zachary (Zach) (Roivant 202402 CEO + Co-Founder of VantAI) |
Chief Executive Officer (CEO) |
Roivant (Group) |
United States (USA) |
Carr, Grant (Albany Molecular 201702 Senior Director Lead Discovery) |
President/Director/Head Business Group/Unit/Division |
Curia (Group) |
United States (USA) |
Carrier, Mark (Hamilton 201303 Market Segment Manager at Hamilton Company) |
Product Manager (personnel) |
Hamilton (Group) |
United States (USA) |
Carrillo, Cristina (ResearachGate 202307) |
n. a. |
ResearchGate (Group) |
Germany |
Carroll, Darren (Polaris Partners 202012) |
Investment Manager |
Polaris Partners (Polaris Ventures) |
United States (USA) |
Carroll, Jill (GSK 201810 Principal at SR One) |
Principal (venture capital) |
SR One (Group) |
United States (USA) |
Carron, Erin (Tempus 202409 Media Contact) |
Public Relations Manager / Investor Relations Manager |
Tempus (Group) |
United States (USA) |
Carstensen, Peter Harry (Schleswig-Holstein (govt) 201007 Minister President + CDU) |
Minister |
Schleswig-Holstein (govt region) |
Germany |
Cartellieri, Simone (GALAB Technologies) |
n. a. |
GALAB Technologies GmbH |
Germany |
Carter, Adrian (Boehringer Ingelheim 201207 Corporate VP Global Research Networking) |
Business Development Manager / Strategy Manager |
Boehringer Ingelheim (Group) |
Germany |
Carter, Stephen A. (Informa 201401– CEO before non-executive Board Director) |
Chief Executive Officer (CEO) |
Informa (Group) [NEW] |
Switzerland |
Carter, Tina (GenScript 202311 Corporate Communications Lead at Legend Biotech) |
Public Relations Manager / Investor Relations Manager |
GenScript (Group) |
United Kingdom (GB) |